Comparison of terbinafine and clotrimazole in treating tinea pedis.
نویسندگان
چکیده
OBJECTIVE To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis. DESIGN Multicentre, double blind parallel group study. SETTING 32 general practices and one hospital. PATIENTS 256 patients with mycologically confirmed tinea pedis. Of the 211 patients evaluable, 107 were randomised to terbinafine (75 male, 32 female; mean (range) age 40 (12-81) years) and 104 to clotrimazole (79 male, 25 female; mean (range) age 36 (12-71) years). INTERVENTIONS Terbinafine 1% cream applied twice daily for one week and inert cream applied twice daily for the next three weeks. Clotrimazole 1% cream applied twice daily for four weeks. MAIN OUTCOME MEASURES Mycological cure (negative results on microscopy and culture) and effective treatment (mycological cure plus no or minimal signs and symptoms) measured at weeks 1, 2, 3, 4, and 6. RESULTS At week four rates of mycological cure were 93.5% for terbinafine and 73.1% for clotrimazole (p = 0.0001); and at week six 97.2% for terbinafine and 83.7% for clotrimazole (p = 0.001). Rates of effective treatment at week 4 were 89.7% for terbinafine and 58.7% for clotrimazole (p = 0.0001); and 89.7% for terbinafine and 73.1% for clotrimazole (p = 0.002) at week 6. CONCLUSION These results indicate that a one week course of terbinafine 1% cream is more effective in the treatment of tinea pedis than a four week course of clotrimazole 1% cream, both in terms of mycological cure and effective treatment.
منابع مشابه
Clinical implications
* Tinea pedis (athlete's foot) occurs in about 15% ofthe population * Its usual treatment is a topical antifungal applied two or three times a day for up to four weeks * Terbinafine is a synthetic allylamine antifungal with a primarily fungicidal action against dermatophytes and some other moulds and yeasts * This study shows that terbinafine 1% cream applied twice daily for a week was signific...
متن کاملButenafine hydrochloride: for the treatment of interdigital tinea pedis.
Butenafine, a derivative of benzylamine with potent fungicidal activity is a new generation of antimycotic compound that has shown to be extremely effective against experimentally-induced tinea pedis in the guinea-pig, a situation that resembles synergetic pathology similar to that of tinea pedis in humans. Butenafine, (N-4-tert-butylbenzyl-N-methyl-1-naphthalenemethyl-amine hydrochloride) with...
متن کاملمقایسه اثر درمانی کرم کلوتریمازول 1% با کرم تربینافین 1% در درمان بیماران مبتلا به درماتوفیتوز بدن و کشاله ران در شهرستان کاشان
Background and Aim: Dermatophytosis is a skin infection without involving of hair, and in fact, Tinea cruris is a form of body Dermatophytosis. For treatment of these two diseases, topical azole or Alylamines are usually used. The aim of this study was to determine the therapeutic effectiveness of Terbinafine 1% and clotrimazole 1%, respectively. Materials and Methods: 100 patients suspected...
متن کاملFungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
Terbinafine, a synthetic allylamine, exerts fungicidal activity against dermatophytes, the causative pathogens of tinea pedis. As proven in numerous clinical trials, tinea pedis can be effectively and safely treated by topical terbinafine. In fact, a 1-week application of terbinafine 1% cream eradicated fungal pathogens at least as effectively as 4-week treatment courses with topical azole deri...
متن کاملA Pediatric Case of Bullous Tinea Pedis Caused by Trichophyton violaceum in the United States
Trichophyton violaceum is an uncommon cause of tinea pedis. We report a case of bullous tinea pedis caused T. violaceum in a 7-year old otherwise healthy child living in the United States. She achieved clinical recovery with a 1month course of oral terbinafine.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 307 6905 شماره
صفحات -
تاریخ انتشار 1993